# MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer

> **NCT06204484** · NA · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 349 (estimated)

## Conditions studied

- Colorectal Cancer

## Interventions

- **OTHER:** CAPEOX adjuvant therapy
- **OTHER:** deferred CAPEOX adjuvant therapy
- **OTHER:** mFOLFOXIRI intensive adjuvant therapy

## Key facts

- **NCT ID:** NCT06204484
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-26
- **Primary completion:** 2028-07-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 349 (ESTIMATED)
- **Last updated:** 2024-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06204484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06204484, "MRD-guided Deferred Adjuvant Therapy in Resectable Early-stage Colon Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06204484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*